2023-12-05T23:41:07+00:00

Soleno Therapeutics

Common Stock & Concurrent Private Placement

$129,000,000

.

Co-Manager
October 2023

2023-04-24T20:59:32+00:00

Serve Robotics Inc

Secured Convertible Debenture

$3,000,000

.

Introducing Broker
April 2023

2023-04-19T13:01:38+00:00


PD Theranostics

Series A Financing

$3,000,000

.

Exclusive Placement Agent
April 2023

2023-03-02T17:04:43+00:00

Guerilla RF, Inc

PIPE Transaction

$9,200,000

.

Exclusive Placement Agent
February 2023

2022-12-19T17:18:52+00:00


NLS Pharmaceutics

Private Placement

$10,000,000 of up to $30,000,000

Investor: BVF Partners L.P.

Exclusive Introducing Broker
December 2022

2023-01-05T20:28:51+00:00

Perfect Moment

Private Placement

$6,000,000

.

Exclusive Placement Agent
October 2022

2023-03-02T16:42:04+00:00

Silo Pharma

Follow-On Offering

$5,750,000

.

Sole Book runner
September 2022

2022-12-19T17:29:28+00:00


Perfect Moment

Secured Convertible Note

.

$10,000,000

Exclusive Placement Agent
June 2022

2022-03-31T20:35:18+00:00


Soleno Therapeutics

Follow-On Offering
Common Stock
and Warrants

$15,000,000

Co-Manager
March 2022

2022-01-17T17:57:40+00:00

MEI
Pharma

PIPE Transaction
Follow-on Offering
Common Stock

$52,325,000

Financial Advisor
December 2021

2022-01-17T18:11:46+00:00


aTyr Pharma Inc.

Follow-On Offering
Common Stock
 

$86,250,000

Lead Manager
September 2021

2022-01-18T14:13:53+00:00

 
Perfect Moment

Private
Placement
 

$6,000,000

Exclusive Placement Agent
May 2021

2022-01-15T17:34:02+00:00


iCAD Inc.

Follow-On Offering
Common Stock
.

$25,000,000

Co-Manager
March 2021

2022-01-18T14:14:20+00:00

Aerwave
Medical

Series A
Offering
 

$4,000,000

Exclusive Placement Agent
February 2021

2022-01-15T17:24:47+00:00


Evoke Pharma

Follow-On Offering
Common Stock
.

$14,375,000

Sole Book-Runner
January 2021

2022-01-15T17:05:00+00:00


Affimed

Follow-On Offering
Common Stock
.

$115,00,000

Co-Manager
January 2021

2022-01-18T14:14:47+00:00

 
PD Theranostics

Series A Offering
 
 

$3,000,000

Exclusive Placement Agent
August 2020

2022-01-18T14:15:14+00:00

Voltron
Therapeutics

Series A
Preferred Offering
 

$3,500,000

Exclusive Placement Agent
June 2020

2022-02-03T15:49:41+00:00

Algorithm
Sciences

Series A
Offering

$3,500,000

Exclusive Placement Agent
February 2020

2022-01-15T18:04:35+00:00


Affimed

Follow-On Offering
Common Stock
.

$34,500,000

Co-Manager
November 2019

2022-01-15T19:23:03+00:00

MEI
Pharma

PIPE Transaction
Common Stock and
Warrants

$75,000,000

Co-Placement Agent
May 2018

2022-01-15T19:22:31+00:00

Sesen
Bio

Registered Direct
Common Stock and
Warrants

$10,000,000

Exclusive Placement Agent
March 2018

2022-01-15T19:18:09+00:00


AIT Therapeutics

PIPE Transaction
Warrants
.

$9,820,154.54

Exclusive Placement Agent
February 2018

2022-01-15T19:23:26+00:00


Affimed

Follow-On Offering
Common Stock
 

$23,000,000

Financial Advisor
February 2018

2022-01-15T19:28:02+00:00

Cytori
Therapeutics

Rights Offering
Convertible Preferred
Stock and Warrants

$10,000,000

Financial Advisor
November 2017

2022-01-15T19:28:54+00:00

Onconova
Therapeutics

Registered Direct
Common Stock
 

$1,380,000

Sole Placement Agent
November 2017

2022-01-16T20:40:18+00:00


US Gold Corporation

Confidentially Marketed Public Offering
Common Stock

$2,500,000

Sole Book Runner
October 2017

2022-01-16T21:07:38+00:00

Spherix, Inc.

Follow-On Offering
 
 

$2,500,000

Sole Book Runner
July 2017

2022-01-16T21:09:46+00:00

Repros
Therapeutics

Confidentially Marketed
Public Offering
Common Stock and Warrants

$3,000,000

Sole Book-Runner
May 2017

2022-01-16T21:10:41+00:00

Onconova
Therapeutics

Confidentially Marketed
Public Offering
Common Stock

$5,963,517

Sole Book Runner
April 2017

2022-01-16T21:11:01+00:00


BioSig Technologies

PIPE Transaction
Common Stocks
& Warrants

$4,349,954

Exclusive Placement Agent
March 2017

2022-01-17T17:41:37+00:00


AIT Therapeutics

PIPE Transaction,
Common Stock
and Warrants

$10,200,000

Placement Agent
March 2017

2022-01-16T21:12:29+00:00

Therapix
Biosciences

Initial Public Offering
Common Stock
 

$13,800,000

Sole Book Runner
March 2017